Clinical trial
A Prospective, Multicenter Real-world Study of HAL-PDT for Cervical Intraepithelial Neoplasia Grade 2
NCT07634497 is registered in ClinicalTrials.gov with Peking Union Medical College Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Multicenter Real-world Study of HAL-PDT for Cervical Intraepithelial Neoplasia Grade 2
- Lead sponsor
- Peking Union Medical College Hospital
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- June 15, 2026
- Completion date
- December 15, 2029
- Enrollment
- 500 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
cervical intraepithelial neoplasia grade 2 (cin2)